Methods and Materials for Producing Polyols and Electron Rich Compounds
US-2021002620-A1 · Jan 7, 2021 · US
US12522848B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12522848-B2 |
| Application number | US-202017779561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 17, 2020 |
| Priority date | Dec 18, 2019 |
| Publication date | Jan 13, 2026 |
| Grant date | Jan 13, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to host cells and their use wherein the host cells are capable of producing D-ribulose and incapable of or have a reduced capability of converting D-ribulose to a molecule other than ribitol, wherein the host cells comprise a heterologous nucleic acid sequence encoding a polypeptide capable of converting D-ribulose to ribitol with a cofactor preference for NADPH.
Opening claim text (preview).
What is claimed is: 1 . A host cell that is capable of producing D-ribulose, wherein the host cell comprises one or more heterologous nucleic acids encoding a polypeptide capable of converting D-ribulose to ribitol selected from: (a) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 7, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively; (b) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively; and (c) a nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 11, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively; wherein the host cell comprises an endogenous gene encoding a polypeptide that is capable of converting D-ribulose to D-arabitol, wherein said endogenous gene is inactivated through deletion of the gene, and wherein the host cell is a yeast cell. 2 . The host cell of claim 1 , wherein the host cell is capable of producing D-ribulose from D-glucose. 3 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 7, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively. 4 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 9, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 5 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 11, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively. 6 . The host cell of claim 1 , wherein the yeast cell is Pichia ohmeri. 7 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 7. 8 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 9. 9 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising SEQ ID NO 11. 10 . The host cell of claim 1 , wherein the host cell comprises more than one of the heterologous nucleic acids encoding a polypeptide capable of converting D-ribulose to ribitol. 11 . The host cell of claim 10 , wherein the host cell comprises (a) a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO:7, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively, and (b) a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 12 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 7, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 7, respectively. 13 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 9, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 45 and 46 of the polypeptide of SEQ ID NO: 9, respectively. 14 . The host cell of claim 1 , wherein the host cell comprises a heterologous nucleic acid encoding a polypeptide capable of converting D-ribulose to ribitol comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 11, and wherein said polypeptide has a serine and an arginine at the positions corresponding to positions 38 and 39 of the polypeptide of SEQ ID NO: 11, respectively. 15 . A method for producing ribitol comprising culturing the host cell of claim 1 under cell culture conditions, wherein ribitol is produced by the host cell. 16 . The method of claim 15 , further comprising isolating the produced ribitol.
for fungi · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
Yeasts; Culture media therefor · CPC title
polyhydric · CPC title
Oxidoreductases (1.) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.